Minireviews
Copyright ©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 354-371
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.354
Table 2 Studies that analyzed the prevalence of cirrhosis among patients with nonalcoholic fatty liver disease-related hepatocellular carcinoma and in controls with other etiologies-related hepatocellular carcinoma
Ref.
n
Prevalence of cirrhosis (in percentage)
Ertle et al[18]36 NAFLD52.8
35 HCV94.3 in HCV
29 HBV93.1 in HBV
19 ALD94.7 in ALD
Reddy et al[31]52 NAFLD73.1
162 HCV/ALD93.8
Dyson et al[20]136 NAFLD77.2
178 ALD100 in ALD
65 HCV96.9 in HCV
29 HBV82.7 in HBV
Mittal et al[33]107 NAFLD65.4
1133 ALD88.9 in ALD
952 HCV91.1 in HCV
65 HBV92.3 in HBV
Piscaglia et al[19]145 NAFLD53.8
611 HCV97.2 in HCV
Yasui et al[17]8751
No control groupNA